Vera Therapeutics Inc (NASDAQ:VERA) traded at $31.74 at close of the session on Monday, June 02 and made an upward move of 67.49% on its previous day’s price.
Vera Therapeutics Inc has a market cap of $2.02 billion and is expected to release its quarterly earnings report in July.
On the other hand, looking at the outlook for the VERA stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Sell.
Based on estimates by 5 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Vera Therapeutics Inc (VERA) stock as a Hold, while 3 rate it as a Buy. 1 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 46.88% off its SMA20 and 40.67% from its 50-day simple moving average. The RSI (14) is pointing at 74.66 while the volatility over the past week is 26.23% and jumps to 12.58% over the past one month. The beta value is 1.13, while the average true range (ATR) is currently pointing at 2.12. The average price target for the stock over the next 12 months is $34, with the estimates having a low of $6 and a high of $38. These price ends are 81.1% and -19.72% off the current price level respectively, although investors could be excited at the prospect of a -7.12% if the VERA share price touches on the median price of $34.
